Debbie Hay | |
---|---|
Born | Deborah Lucy Hay |
Alma mater | Imperial College London |
Scientific career | |
Fields | molecular pharmacology |
Institutions | |
Thesis |
Deborah Lucy Hay FRSNZ is a New Zealand academic. [1] In 2022, she was elected a Fellow of the Royal Society Te Apārangi.
After an undergraduate in pharmacology at the University of Sheffield, Hay did a PhD in molecular pharmacology entitled 'Investigation of the calcitonin receptor-like receptor and receptor activity modifying proteins' at Imperial College London. Hay moved to the University of Auckland, where she rose to full professor. She is now a full professor at the University of Otago and is a Fellow of the British Pharmacological Society.
Her research involves molecular pharmacological techniques [2] to investigate phenomenon such as migraines. [3] [4] In 2016 she was awarded a James Cook Research Fellowship to investigate the causes and potential new treatments for migraines. [5]
In 2022, Hay was elected a Fellow of the Royal Society Te Apārangi. The society said "Professor Debbie Hay is an innovative molecular pharmacologist whose seminal contributions have enhanced understanding of the roles of G protein-coupled receptors (GPCRs) in conditions such as migraine, diabetes and obesity... ...she has established herself as a world leader in a complex field, in high demand internationally as a collaborator, speaker, writer and consultant to industry." [6]
Debbie Hay | |
---|---|
Born | Deborah Lucy Hay |
Alma mater | Imperial College London |
Scientific career | |
Fields | molecular pharmacology |
Institutions | |
Thesis |
Deborah Lucy Hay FRSNZ is a New Zealand academic. [1] In 2022, she was elected a Fellow of the Royal Society Te Apārangi.
After an undergraduate in pharmacology at the University of Sheffield, Hay did a PhD in molecular pharmacology entitled 'Investigation of the calcitonin receptor-like receptor and receptor activity modifying proteins' at Imperial College London. Hay moved to the University of Auckland, where she rose to full professor. She is now a full professor at the University of Otago and is a Fellow of the British Pharmacological Society.
Her research involves molecular pharmacological techniques [2] to investigate phenomenon such as migraines. [3] [4] In 2016 she was awarded a James Cook Research Fellowship to investigate the causes and potential new treatments for migraines. [5]
In 2022, Hay was elected a Fellow of the Royal Society Te Apārangi. The society said "Professor Debbie Hay is an innovative molecular pharmacologist whose seminal contributions have enhanced understanding of the roles of G protein-coupled receptors (GPCRs) in conditions such as migraine, diabetes and obesity... ...she has established herself as a world leader in a complex field, in high demand internationally as a collaborator, speaker, writer and consultant to industry." [6]